Walleye Capital’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.95K Sell
78
-13,589
-99% -$322K ﹤0.01% 4238
2025
Q4
$360K Buy
13,667
+13,591
+17,883% +$296K ﹤0.01% 3170
2025
Q3
$1.3K Buy
+76
New +$1.09K ﹤0.01% 4367
2025
Q2
Sell
-247,959
Closed -$2.95M 5128
2025
Q1
$2.95M Sell
247,959
-204,845
-45% -$2.79M 0.01% 1152
2024
Q4
$6.63M Buy
+452,804
New +$6.33M 0.02% 894
2024
Q3
Sell
-26,374
Closed -$224K 5955
2024
Q2
$224K Buy
+26,374
New +$235K ﹤0.01% 4217
2023
Q4
Sell
-11,468
Closed -$72.7K 5618
2023
Q3
$72.7K Buy
+11,468
New +$84.7K ﹤0.01% 4077
2022
Q3
Sell
-204,096
Closed -$1.08M 3610
2022
Q2
$1.08M Sell
204,096
-72,211
-26% -$437K 0.03% 608
2022
Q1
$1.81M Buy
+276,307
New +$2.46M 0.05% 403

Other funds holding ZYME

Walleye Capital's ZYME Position: Q1 2026 in Review

Walleye Capital reduced its Zymeworks (ZYME) stake by 99% in Q1 2026, selling an estimated $322K and leaving 78 shares worth $1.95K. The position accounts for ﹤0.01% of the portfolio, ranked #4238.

Walleye Capital first reported a position in ZYME in Q1 2022 and has held it in 9 quarters since. The position peaked at $6.63M in Q4 2024. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • Walleye Capital held 78 shares of Zymeworks worth $1.95K as of Q1 2026.
  • Walleye Capital sold 13,589 Zymeworks shares in Q1 2026, an estimated $322K.
  • Zymeworks made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #4238 holding.
  • Walleye Capital first reported a position in Zymeworks in Q1 2022 and has held it in 9 quarters since.
  • Walleye Capital's Zymeworks position peaked at $6.63M in Q4 2024.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.